Samit Hirawat is EVP,Chief Med.Offr.,Drug Dev. of BRISTOL MYERS SQUIBB CO. Currently has a direct ownership of 83,513 shares of BMY, which is worth approximately $3.93 Million. The most recent transaction as insider was on Jul 01, 2020, when has been sold 9,356 shares (Common Stock, $0.10 par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 83.5K
30.63% 3M change
38.54% 12M change
Total Value Held $3.93 Million

Samit Hirawat Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2020
BUY
Exercise of conversion of derivative security
-
9,356 Added 50.0%
9,356 Common Stock, $0.10 pa...
SH

Samit Hirawat

EVP,Chief Med.Offr.,Drug Dev.
New York, NY

Track Institutional and Insider Activities on BMY

Follow BRISTOL MYERS SQUIBB CO and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMY shares.

Notify only if

Insider Trading

Get notified when an Bristol Myers Squibb CO insider buys or sells BMY shares.

Notify only if

News

Receive news related to BRISTOL MYERS SQUIBB CO

Track Activities on BMY